...
机译:雷贝拉唑控制兰索拉唑治疗失败的患者的GERD症状:“ Cluster GERD”的首次报道
Veterans Administration Greater Los Angeles Healthcare System and CURE: VA/UCLA Digestive Diseases Research Center Division of Digestive Diseases David Geffen School of Medicine at University of California;
Veterans Administration Greater Los Angeles Healthcare System and CURE: VA/UCLA Digestive Diseases Research Center Division of Digestive Diseases David Geffen School of Medicine at University of California;
Veterans Administration Greater Los Angeles Healthcare System and CURE: VA/UCLA Digestive Diseases Research Center Division of Digestive Diseases David Geffen School of Medicine at University of CaliforniaDivision of Gastroenterology and Hepatology VA Greater Los Angeles Healthcare System (111C);
gastroesophageal reflux disease; proton pump inhibitor; gastric acid secretion;
机译:夜间GERD症状患者入睡后立即释放奥美拉唑口服混悬液,兰索拉唑缓释胶囊和埃索美拉唑缓释胶囊对夜间胃酸度的影响比较。
机译:兰索拉唑和埃索美拉唑在有症状的Gerd病患者中进行的双盲,随机,多中心试验在3000名患者中证实了类似的症状缓解
机译:GERD患者的治疗方式和症状控制:美国社区调查。
机译:吞咽声波分析对GERD患者正常和吞咽困难的分类
机译:通过练习CRNA在患者报告GERD中使用喉部面罩气道
机译:雷贝拉唑控制兰索拉唑治疗失败的患者的GERD症状: Cluster GERD的首次报道
机译:12 - IW-3718,一种新型胃保留胆汁酸螯合剂的影响,在持续的GERD患者接受PPI的患者的一系列曲线症状上 - 来自双盲,安慰剂对照研究的结果
机译:mycoleptodiscus terrestris(Gerd。)Ostazeski第一种商业配方的田间试验作为欧亚水蛾的Blocontrol